CTRI/2011/10/002068已完成4 期
Efficacy of Eptifibatide in acute coronary syndrome in Asian Indian patients
Fulford India Ltd0 个研究点目标入组 250 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Acute Coronary Syndrome under going percutaneous intervention(PCI)
排除标准
- •1. Severe renal insufficiency
- •2.Thrombocytopenia
- •3. Hemorrhagic stroke
- •4.Local Systemic Bleeds
研究者
相似试验
已完成
4 期
Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-upNon ST Elevation Myocardial InfarctionNCT01863134Medical University of Silesia140
进行中（未招募）
1 期
Assessment of glycemic compensation and hemodynamic parameteres in patients after administration of GLP-1 agonist exenatid during and after the implantation of aortocoronary by-pass.Patients with elective coronary artery bypass grafting with LV systolic dysfunction (EF LV = 50%)MedDRA version: 14.1Level: PTClassification code 10011077Term: Coronary artery bypassSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: HLTClassification code 10012602Term: Diabetes mellitus (incl subtypes)System Organ Class: 10014698 - Endocrine disordersEUCTR2010-023839-42-CZGeneral University Hospital in Prague
招募中
不适用
Efficacy of Empagliflozin on Acute Coronary Syndrome with Type 2 Diabetes: Open-label Randomized Controlled TrialJPRN-UMIN000020951The Sakakibara Heart Institute of Okayama100
已完成
3 期
The Australian COPS trial - COlchicine in Patients with acute coronary SyndromesIschaemic heart diseaseCardiovascular - Coronary heart diseaseACTRN12615000861550St. Vincent's Hospital Melbourne800
招募中
不适用
ife-style intervention in patients with coronary artery disease and/or diabetes mellitusI25.1E11Atherosclerotic heart diseaseType 2 diabetes mellitusDRKS00012341Techniker Krankenkasse500